Robust estimation of the expected survival probabilities from high-dimensional Cox models with biomarker-by-treatment interactions in randomized clinical trials

Documenti analoghi

• Identification of biomarker‐by‐treatment interactions in randomized clinical trials with survival outcomes and high‐dimensional spaces
  di: Ternès, Nils, et al.
  Pubblicazione: (2016)
• Prediction of treatment benefit in high-dimensional cox models via gene signatures in randomized clinical trials
  di: Ternès, Nils, et al.
  Pubblicazione: (2015)
• Accounting for grouped predictor variables or pathways in high-dimensional penalized Cox regression models
  di: Belhechmi, Shaima, et al.
  Pubblicazione: (2020)
• Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis
  di: Lueza, Béranger, et al.
  Pubblicazione: (2016)
• Erratum to: Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis
  di: Lueza, Béranger, et al.
  Pubblicazione: (2016)